Brenda P. Fielding
Direttore/Membro del Consiglio presso Colorado BioScience Association
Profilo
Brenda P.
Fielding is currently the Director at Colorado BioScience Association since 2013.
Prior to this, she held positions such as Director-Regulatory Affairs at Cortech, Inc., Vice President-Regulatory Affairs at Tapestry Pharmaceuticals, Inc., Executive VP-Regulatory & Strategic Development at Clinipace, Inc., and President at Regulus Pharmaceutical Consulting, Inc. from 2011 to 2013.
She also worked as Director-Regulatory Affairs at Gilead Sciences, Inc. from 1999 to 2000.
Ms. Fielding completed her undergraduate degree at the University of London.
Posizioni attive di Brenda P. Fielding
| Società | Posizione | Inizio |
|---|---|---|
Colorado BioScience Association
 Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Colorado BioScience Association operates as an association for life sciences. The non-profit company is based in Denver, CO. The company was founded by Steve A. Orndorff. Jennifer Jones Paton has been the CEO of the company since 2016. | Direttore/Membro del Consiglio | 08/05/2013 |
Precedenti posizioni note di Brenda P. Fielding
| Società | Posizione | Fine |
|---|---|---|
| GILEAD SCIENCES, INC. | Consigliere Generale | 01/01/2000 |
| Cortech, Inc. | Consigliere Generale | - |
Tapestry Pharmaceuticals, Inc.
 Tapestry Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tapestry Pharmaceuticals, Inc. develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel. It focuses on the development of proprietary therapies for the treatment of cancer, new products and technologies may involve the examination of individual molecules and classes of compounds. The company was founded in 1991 and is headquartered in Ankeny, IA. | Consigliere Generale | - |
Clinipace, Inc.
 Clinipace, Inc. Miscellaneous Commercial ServicesCommercial Services Clinipace, Inc. provides digital contract research solutions. The firm operates as a digital contract research organization that assists life science firms in developing and executing regulatory strategies, clinical development, and post-approval research. Its service areas encompass clinical monitoring, data management, medical affairs and writing, patient recruitment, study feasibility, and site selection and management. The company was founded by Ronald G. Marks, Christopher K. Porter, and Jeff Lewis Williams in 2003 and is headquartered in Morrisville, NC. | Consigliere Generale | - |
Regulus Pharmaceutical Consulting, Inc.
 Regulus Pharmaceutical Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd., Regulus Pharmaceutical Consulting, Inc. provides regulatory affairs and quality assurance consulting services. The company is based in Boulder, CO. Regulus Pharmaceutical Consulting was acquired by Clinipace, Inc., part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. from April 28, 2021 on March 01, 2011. | Presidente | - |
Formazione di Brenda P. Fielding
| University of London | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
| Cortech, Inc. | Health Technology |
Tapestry Pharmaceuticals, Inc.
Tapestry Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tapestry Pharmaceuticals, Inc. develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel. It focuses on the development of proprietary therapies for the treatment of cancer, new products and technologies may involve the examination of individual molecules and classes of compounds. The company was founded in 1991 and is headquartered in Ankeny, IA. | Health Technology |
Clinipace, Inc.
Clinipace, Inc. Miscellaneous Commercial ServicesCommercial Services Clinipace, Inc. provides digital contract research solutions. The firm operates as a digital contract research organization that assists life science firms in developing and executing regulatory strategies, clinical development, and post-approval research. Its service areas encompass clinical monitoring, data management, medical affairs and writing, patient recruitment, study feasibility, and site selection and management. The company was founded by Ronald G. Marks, Christopher K. Porter, and Jeff Lewis Williams in 2003 and is headquartered in Morrisville, NC. | Commercial Services |
Colorado BioScience Association
Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Colorado BioScience Association operates as an association for life sciences. The non-profit company is based in Denver, CO. The company was founded by Steve A. Orndorff. Jennifer Jones Paton has been the CEO of the company since 2016. | Commercial Services |
Regulus Pharmaceutical Consulting, Inc.
Regulus Pharmaceutical Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd., Regulus Pharmaceutical Consulting, Inc. provides regulatory affairs and quality assurance consulting services. The company is based in Boulder, CO. Regulus Pharmaceutical Consulting was acquired by Clinipace, Inc., part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. from April 28, 2021 on March 01, 2011. | Commercial Services |
- Borsa valori
- Insiders
- Brenda P. Fielding